These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8529766)

  • 1. [Use of insulin in non-insulin-dependent diabetes (diabetes type 2). Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)].
    Brun JM; Cathelineau G; Charbonnel B; Drouin P; Durlach V; Fontaine P; Guillausseau PJ; Halimi S; Vexiau P; Vialettes B
    Diabete Metab; 1995 Oct; 21(4):291-4. PubMed ID: 8529766
    [No Abstract]   [Full Text] [Related]  

  • 2. [The night of the insulin-dependent diabetic patient. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)].
    Bennis D; Slama G
    Diabetes Metab; 1996 Dec; 22(6):470-5. PubMed ID: 8998699
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
    Bressler R; Johnson DG
    Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Stratton IM; Matthews DR
    Diabet Med; 1997 Aug; 14(8):709-10. PubMed ID: 9272603
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Escaping oral hypoglycemic agents in type 2 diabetes: importance and limitations of transitory optimized insulin therapy].
    Leutenegger M; Bertin E; Grulet H
    Diabetes Metab; 1998 Feb; 24(1):80-4. PubMed ID: 9534015
    [No Abstract]   [Full Text] [Related]  

  • 8. Initiating insulin in type 2 diabetes mellitus: the earlier the better.
    Cohen O
    Isr Med Assoc J; 2004 May; 6(5):292-4. PubMed ID: 15151371
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral hypoglycemic agents.
    Lebovitz HE
    Prim Care; 1988 Jun; 15(2):353-69. PubMed ID: 3290924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-insulin-dependent diabetes mellitus.
    Edelman SV; Henry RR
    Curr Ther Endocrinol Metab; 1997; 6():430-8. PubMed ID: 9174785
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment: insulin strategies for type 2 diabetes mellitus.
    Davidson JA
    Ann Pharmacother; 2005 May; 39(5):975-6; author reply 976. PubMed ID: 15811902
    [No Abstract]   [Full Text] [Related]  

  • 13. Initiating insulin in type 2 diabetes.
    Ravina A
    Isr Med Assoc J; 2004 Dec; 6(12):787. PubMed ID: 15609901
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of insulin treatment in type 2 diabetes.
    Del Prato S
    Int J Clin Pract Suppl; 1999 Sep; 107():18-22. PubMed ID: 10692728
    [No Abstract]   [Full Text] [Related]  

  • 15. [Insulin sparing and metabolic control with metformin-insulin combination].
    Isnard F
    Journ Annu Diabetol Hotel Dieu; 1997; ():305-25. PubMed ID: 9296986
    [No Abstract]   [Full Text] [Related]  

  • 16. [Type 2 diabetes: when and how to start insulin treatment?].
    Philippe J
    Rev Med Suisse Romande; 2004 Mar; 124(3):129-32. PubMed ID: 15095654
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin therapy for type 2 diabetes.
    Pergallo-Dittko V
    Diabetes Self Manag; 2003; 20(5):17, 21, 23-4. PubMed ID: 14679948
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medical treatment of type 2 diabetes. French Agency for the Health Safety of Health Products].
    Diabetes Metab; 1999 Dec; 25(6):533-50. PubMed ID: 10633881
    [No Abstract]   [Full Text] [Related]  

  • 19. [Insulin therapy in type 2 diabetes: short-acting insulin analog has advantages].
    MMW Fortschr Med; 2006 Jun; 148(26):56-7. PubMed ID: 16875384
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-acting insulin analogues vs. human insulin for diabetes.
    Schooff M; Ehlers K
    Am Fam Physician; 2005 Sep; 72(5):805-7. PubMed ID: 16156336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.